BUCHANG PHARMA
60385815.620.06% ( -0.01 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: BUCHANG PHARMA(603858) the Revenue is 2.579 B (-7.39%);the EBIT is 433.07 M (+6.58%);the EPS is 0.305 (+5.04%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
2.58B7.39%
----
----
EBIT
0.43B6.58%
----
----
EPS
0.30455.04%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf